We Are Honored to be Named As One of TIME Magazine's 50 Genius Companies For Our Work in Advancing Cannabinoid Science

Our Story

We've achieved this distinction through innovation and persistence.

 

Medical Information

Access scientific and clinical information on Greenwich Biosciences products.

READ MORE

Spotlight News

Spotlight News
Apr 25, 2018
Greenwich Clinical Program Reflects Dedication to Scientific Rigor, Unmet Patient Needs
READ MORE >

Press Releases

Nov 1, 2018
EPIDIOLEX® (cannabidiol) Oral Solution – the First FDA-approved Plant-derived Cannabinoid Medicine – Now Available by Prescription in the U.S.
Read More >

Patients & Caregivers

“Our primary purpose is to make a positive and meaningful difference in the lives of patients and their caregivers.”

–Justin Gover,
Chief Executive Officer 

 

Careers

Become part of a dynamic, cutting-edge pharmaceutical company on the forefront of a new category of therapeutic treatment.